Compare BAM & COR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BAM | COR |
|---|---|---|
| Founded | 2022 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Other Pharmaceuticals |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 70.7B | 68.5B |
| IPO Year | 2022 | 2001 |
| Metric | BAM | COR |
|---|---|---|
| Price | $43.95 | $312.85 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 13 |
| Target Price | $63.00 | ★ $395.23 |
| AVG Volume (30 Days) | ★ 3.7M | 1.3M |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | ★ 4.20% | 0.77% |
| EPS Growth | N/A | ★ 5.71 |
| EPS | N/A | ★ 2.87 |
| Revenue | $4,817,000,000.00 | ★ $321,332,819,000.00 |
| Revenue This Year | $29.85 | $8.91 |
| Revenue Next Year | $15.22 | $6.84 |
| P/E Ratio | ★ $34.43 | $108.62 |
| Revenue Growth | ★ 21.03 | 9.31 |
| 52 Week Low | $41.78 | $267.40 |
| 52 Week High | $64.10 | $377.54 |
| Indicator | BAM | COR |
|---|---|---|
| Relative Strength Index (RSI) | 41.45 | 30.09 |
| Support Level | N/A | $289.56 |
| Resistance Level | $45.17 | $315.23 |
| Average True Range (ATR) | 1.09 | 8.58 |
| MACD | 0.19 | -3.10 |
| Stochastic Oscillator | 56.57 | 5.54 |
Brookfield Asset Management Ltd is an alternative asset manager with over $1 trillion of Assets Under Management across infrastructure, renewable power and transition, private equity, real estate, and credit. It offers a range of alternative investment products to over 2,400 institutional clients around the world-including public and private pension plans, endowments and foundations, sovereign wealth funds, financial institutions, insurance companies and private wealth investors which also continues to grow with approximately 60,000 clients representing over 8% of capital raised. The company provide a diversified suite of alternative investment strategies to its clients and are constantly seeking to innovate new strategies to meet their needs.
Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health hold over 90% share of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.